This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: Paul Richard Sebahar: Innovator in Chemical Compounds
Introduction
Paul Richard Sebahar is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of chemical compounds, particularly in the development of non-nucleoside reverse transcriptase inhibitors. With a total of 3 patents, his work has had a profound impact on medical treatments.
Latest Patents
Sebahar's latest patents focus on innovative chemical compounds. One of his inventions relates to compounds that serve as non-nucleoside reverse transcriptase inhibitors, which are crucial in the treatment of human immunodeficiency virus infection. Another patent involves compounds that are useful in treating human papillomaviruses, along with methods for their preparation and use.
Career Highlights
Throughout his career, Sebahar has worked with prominent companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and GlaxoSmithKline LLC, where he contributed to various research and development projects.
Collaborations
Sebahar has collaborated with several professionals in his field, including Sharon Davis Boggs and Kristjan S Gudmundsson. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Paul Richard Sebahar's contributions to the field of chemical compounds demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a significant inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile